Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuraxis (NRXS) Return on Equity (2023 - 2025)

Neuraxis (NRXS) has disclosed Return on Equity for 3 consecutive years, with 2.78% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 5075.0% to 2.78% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 2.78% through Dec 2025, up 5075.0% year-over-year, with the annual reading at 2.89% for FY2025, 2041.0% up from the prior year.
  • Return on Equity hit 2.78% in Q4 2025 for Neuraxis, down from 2.33% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 5.69% in Q4 2023 to a low of 53.53% in Q4 2024.
  • Historically, Return on Equity has averaged 4.4% across 3 years, with a median of 0.59% in 2023.
  • Biggest five-year swings in Return on Equity: crashed -5922bps in 2024 and later soared 5075bps in 2025.
  • Year by year, Return on Equity stood at 5.69% in 2023, then plummeted by -1040bps to 53.53% in 2024, then soared by 95bps to 2.78% in 2025.
  • Business Quant data shows Return on Equity for NRXS at 2.78% in Q4 2025, 2.33% in Q3 2025, and 3.2% in Q2 2025.